Defending Our Nation

September 30, 2009 12:46 am admin Business

In an age where terrorism and the use of bio-warfare is a very real threat, there is a lot of money to be made in the development and production of vaccines.  Emergent BioSolutions Incorporated, with Fuad El-Hibri at the helm as Chief Executive Officer, have already posted a net income of $26 million for the first half of the year.  This company is a leading bio-pharmaceutical company who develops vaccines and whose main success story is the product BioThrax.  The companies successful performance can primarily be attributed to the growth in sales of the BioThrax vaccine and their contract with the United States government to manufacture and deliver this product.  They are successfully getting this vaccine on the shelves so that Americans do not have to live in fear of the anthrax disease.